GLP-1 medications are now the go-to weight loss solution for millions of Americans. With 1 in 8 Americans having tried them, demand is clear and so are the challenges. Side effects like gastrointestinal discomfort and muscle loss are driving 50-75% (of patients) to discontinue use within a year. Join our webinar as we go beyond clinical trials and explore Kerry’s recent consumer perception study with GLP-1 users taking BC30 probiotic. We will uncover why users discontinue their GLP-1 regiment, how Kerry’s BC30 helps support the GLP-1 journey, and how brands can step in with solutions that could make a difference.
